Conference Coverage
Latest News
Novel trastuzumab duocarmazine significantly improved survival in advanced HER2-positive breast cancer
Trastuzumab duocarmazine is a novel HER2-targeting antibody-drug conjugate which, according to the results of the TULIP trial recently presented...
Conference Coverage
Treatment shows 'important improvements' in triple-negative breast cancer
Survival of patients without an initial diagnosis of triple-negative breast cancer was better with the antibody-drug conjugate, compared with...
Conference Coverage
Response to preop immunotherapy predicts survival in early NSCLC
For each 10% increase of residual viable tumor, risk of death was increased 64% and risk of recurrence was increased 71%.
Conference Coverage
Migraine history linked to more severe hot flashes in postmenopausal women
Researchers suspect the association between vasomotor symptoms and migraine could result from a common cause in neurovascular dysregulation, but...
Conference Coverage
‘Metabolically healthy obesity’ tied to substantial heart risk
There was an increased risk for both new-onset heart failure and atrial fibrillation in people who were obese with no metabolic abnormalities.
Conference Coverage
Age, C-reactive protein predict COVID-19 death in diabetes
“This means we can easily identify patients early on in their hospital stay who will likely require more aggressive interventions to try and...
Conference Coverage
Women with type 2 diabetes get fewer cardioprotective drugs than do men
“This is confirmation that women are less well managed than men when it comes to cardiovascular risk, especially if they have [type 2] diabetes...
Conference Coverage
Time-restricted eating: An easy way to improve metabolic health?
"Time-restricted eating is an easy-to-follow and effective dietary strategy that requires less mental math than counting calories."
Conference Coverage
Studies confirm survival benefit with postchemoradiotherapy consolidation in NSCLC
The findings show a progression-free survival benefit in patients who underwent concurrent or sequential chemoradiotherapy giving insight to real-...
Conference Coverage
Once daily poziotinib shows efficacy in non–small cell lung cancer
No effective treatments exist for patients with NSCLC with EGFR and HER2 exon 20 mutations, but now a new study shows that poziotinib 16 mg daily...
Conference Coverage
PCOS linked to menopausal urogenital symptoms but not hot flashes
The lack of an association between PCOS and severe vasomotor symptoms was surprising since each of these is linked to a greater risk of...